SWISS SUICIDE GROUP UNDER INVESTIGATION
The Swiss assisted suicide group Dignitas is being investigated after a healthy 69-year-old German woman killed herself with its help. The woman, who has not been named for legal reasons, approached Dignitas with a fake medical report saying that she had terminal cirrhosis of the liver. But a routine autopsy by authorities when her body was returned to Germany revealed that this was false. It turned out that her doctor in Augsberg had given her a false medical certificate as a way of helping her to get sick leave from work.
Another casualty was the Swiss doctor who provided the woman with a lethal dose of barbiturates. When he learned that she had not been terminally ill, he committed suicide. Nonetheless, the head of Dignitas, Ludwig Minelli, defended the work of his organisation. “The doctor’s report that I was given indicated the woman was suffering from cirrhosis of the liver as well as hepatitis,” he said. “And in any case every person in Europe has the right to choose to die, even if they are not terminally ill.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...